Antiviral Efficacy of Fluoxetine in Early Symptomatic COVID-19: an Open-Label, Randomised, Controlled, Adaptive Platform Trial (PLATCOV)
Podjanee Jittamala,Simon Boyd,William HK Schilling,James A Watson,Thundon Ngamprasertchai,Tanaya Siripoon,Viravarn Luvira,Elizabeth M Batty,Phrutsamon Wongnak,Lisia M Esper,Pedro J Almeida,Cintia Cruz,Fernando R Ascencao,Renato S Aguiar,Najia K Ghanchi,James J Callery,Shivani Singh,Varaporn Kruabkontho,Thatsanun Ngernseng,Jaruwan Tubprasert,Wanassanan Madmanee,Kanokon Suwannasin, Amornrat Promsongsil,Borimas Hanboonkunupakarn,Kittiyod Poovorawan,Manus Potaporn,Attasit Srisubat,Bootsakorn Loharjun,Walter RJ Taylor, Farah Qamar,Abdul Momin Kazi, M. Asim Beg,Danoy Chommanam, Sisouphanh Vidhamaly,Kesinee Chotivanich,Mallika Imwong,Sasithon Pukrittayakamee,Arjen M Dondorp,Nicholas PJ Day,Mauro M Teixeira,Watcharapong Piyaphanee,Weerapong Phumratanaprapin,Nicholas J White, the PLATCOV Collaborative Group medrxiv(2024)
AI 理解论文
溯源树
样例